Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents

Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents

US Patent 11192902 · Granted Dec 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic inhibition affinity of copper (II) complex and their diazenyl pyridi2023
Pyridine derivatives for the treatment of hyperproliferative diseases2022
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Di(2-aryl hydrozonopropanal) arene derivatives2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Potent cytotoxic agent against human hepatocellular carcinoma cell line based on2019
Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacteri2019
Method for making a phosphorus ylide2012